Rizzoli, Giancarlo (4D Lifetec 202310 CEO) |
Chief Executive Officer (CEO) |
4D Lifetec AG |
Switzerland |
Rizzuto, Carlo (Versant Ventures 201810 Partner) |
Partner (venture partner) |
Versant Ventures |
United States (USA) |
Robbers, Thomas (Nano-Bioanalytik-Zentrum-Münster 201107 Managing Director) |
Managing Director |
Nano-Bioanalytik-Zentrum GmbH (NBZ Münster) |
Germany |
Roberts, Tom (Rentschler 202309– President of Rentschler Biopharma Inc + General Manager US before Vitanova Biomedical) |
President/Director/Head Business Group/Unit/Division |
Rentschler (Group) |
United States (USA) |
Robertson, Lindon G. (Brooks Automation 201310– CFO before Graftech International + IBM Corp) |
Chief Financial Officer (CFO) |
Azenta (Group) |
United States (USA) |
Robertson, Neil (Peak Scientific 201710 General Manager EMEA) |
General Manager (management) |
Peak Scientific (Group) |
United Kingdom (GB) |
Robinson, Jim (Sumitomo 202207 CEO of Urovant Sciences) |
Chief Executive Officer (CEO) |
Sumitomo (Group) |
|
Robinson, Peter (Jackson Laboratory for Genomic Medicine 201611 Professor before Charité University Hospital Berlin) |
Professor |
Agilent (Group) |
United States (USA) |
Robinson, Tim (LGC 201710 CEO) |
Chief Executive Officer (CEO) |
LGC (Group) |
United Kingdom (GB) |
Robroeks, Marcel (Steigerwald Arzneimittel GmbH 201305 Managing Director) |
Managing Director |
Bayer (Group) |
Germany |
Rocci, Mario (Solvias 202203 Chair + Advisor Water Street Healthcare Partners) |
Board member, non-executive |
Solvias (Group) |
Switzerland |
Rochat, Bertrand (Univ Lausanne 201410 CHUV) |
n. a. |
University of Lausanne (UNIL) |
Switzerland |
Rocher, Jean-Philippe (Addex 201802– Co-Head Disovery before Pierre Fabre + Addex + Devgen + GSK Japan + Batelle) |
management (personnel) |
Addex (Group) |
Switzerland |
Rochon, Maike (Niedersachsen (govt) 201706 Head + Cluster Manager of BioRegioN at Innovationszentrum Nidersachsen) |
Cluster Manager |
Niedersachsen (govt region) |
Germany |
Rocklage, Scott M. (5AM Ventures 201603 Managing Partner + Founder) |
Managing Partner (investment firm) |
5AM Ventures (US) |
United States (USA) |
Rockman, Glenn (Adjuvant Capital 202301 Managing Partner + Founder formerly GHIF + JP Morgan) |
Managing Partner (investment firm) |
Global Health Investment (Group) |
United States (USA) |
Rodatz, Wolfram (Digilab BioVisioN 200603– before Bio-Rad) |
n. a. |
PXBioVisioN GmbH |
Germany |
Roedder, Ludger (BRAIN 201810–202007 CBO before BASF Corporation 2005–2018 LEFT 7/20) |
Chief Business Officer (CBO) |
BRAIN Biotech (Group) |
Germany |
Roehrig, Klaus (Bamed MAM Group 201904 Co-Owner) |
n. a. |
Bamed MAM Group |
|
Roelofsen, Julia (NineSigma 201504 Business Development Manager at NineSigma Europe) |
Business Development Manager / Strategy Manager |
NineSigma (Group) |
Belgium |
Roerink, Frank C. H. (Avantium 200705– CFO) |
Chief Financial Officer (CFO) |
Avantium (Group) |
Netherlands |
Roesky, Christian (Hopp Group 201611– CEO of Novaliq GmbH before Bausch + Lomb + Abbott + Alcon) |
Chief Executive Officer (CEO) |
HOPP Group (family of Dietmar Hopp) |
Germany |
Roever, Stefan (Genia 201406 CEO before Brokat Technologies) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Rogalla, Piere (ZytoVision GmbH 200405–200902– Managing Director + founder before Alcedo Biotech Managing Director) |
Managing Director |
ZytoVision (Group) |
Germany |
Rohayem, Jacques (Riboxx 201602 CEO + CSO) |
Managing Director |
Riboxx GmbH (Riboxx Pharmaceuticals) |
Germany |
Rohde, Hans Christian (Uniqure 201212–201508 CCO RETIRED 8/15 before GSK/Stiefel + Basilea + Merck Serono) |
Chief Commercial Officer (CCO) |
Uniqure (Group) |
Netherlands |
Rohleder, Bernhard (Bitkom 201711 CEO) |
Chief Executive Officer (CEO) |
Bitkom – Bundesverband Informationswirtschaft, Telekommunkation und neue Medien e. V. |
Germany |
Rohlff, Christian (Oxford BioTherapeutics 201506 CEO before Oxford Genome Sciences CEO) |
Chief Executive Officer (CEO) |
Oxford BioTherapeutics Ltd. (OBT) |
United Kingdom (GB) |
Rohmann, Sven (Immunicum 202011 CEO before Biotech Pharmacon 200810– VP BusDev before Novartis Pharma) |
Chief Executive Officer (CEO) |
Mendus (Group) |
Sweden |
Rohwedder, Hinnerk (Evotec 202209 Senior Specialist Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Evotec (Group) |
Germany |
Roix, Jeffrey (NeoPhore 201804– CEO before PhoreMost + Novartis Institute for Biomedical Research + Constellation) |
Chief Executive Officer (CEO) |
NeoPhore Ltd. |
United Kingdom (GB) |
Rolfs, Arndt (Centogene 201406–202010 CEO + Founder before Univ Rostock Prof RESIGNED 10/20) |
Managing Director |
Centogene (Group) |
Germany |
Rolin, Eric (PregLem SA 200606– CFO before consultant before Warner-Lambert Co) |
Chief Financial Officer (CFO) |
Gedeon Richter (Group) |
Switzerland |
Rolka, Felix Shimon (Evanium Healthcare 201905 Managing Director) |
Managing Director |
Evanium Healthcare GmbH |
Germany |
Romanowski, Piotr (Ryvu Therapeutics 202207 President of Supervisory Board) |
Supervisory Board Member |
Ryvu Therapeutics S.A. (WSE: RVU) |
Poland |
Romero, Petra (Plasmion 202301 Marketing Manager) |
Sales Manager / Marketing Manager |
Plasmion (Group) |
Germany |
Romero, Yannick (Saphetor SA 201601– Head Business Development) |
Business Development Manager / Strategy Manager |
Saphetor S.A. (VarSome) |
Switzerland |
Rommel, Christian (Bayer 202102– Head RnD of Pharma division before Roche + Amgen + Intellikine + Merck Serono) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
Rommelspacher, Hans (AudioCure Pharma GmbH 201705– CSO before CEO + Founder + Professor at Charité Berlin) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
AudioCure Pharma GmbH |
Germany |
Ronacher, Bernhard (Cube Dx 201507 CSO before Anagnostics + Lambda GmbH) |
Managing Director |
Cube Dx GmbH |
Austria |
Ronde, Jörg A. (Greenovation Biotech 201908– Managing Director) |
Managing Director |
Eleva GmbH |
Germany |
Ronnenberg, Jörg (MoBiTec 201011 Managing Director) |
Managing Director |
MoBiTec GmbH |
Germany |
Roozen, Arjan (Ascend GCTx 202305 COO) |
Chief Operating Officer (COO) |
Ascend Gene and Cell Therapies (Ascend GCTx) (Group) |
United Kingdom (GB) |
Rosa, Tom (Bruker 200904 CFO of Bruker Advanced Supercon Inc) |
Chief Financial Officer (CFO) |
Bruker (Group) |
Germany |
Rosat, Jean-Pierre (Aleva Neurotherapeutics 201108 CEO) |
Chief Executive Officer (CEO) |
Aleva Neurotherapeutics S.A. |
Switzerland |
Rosati, Peter (Arxspan 201903 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bruker (Group) |
United States (USA) |
Roschmann, Elke (Epidauros 200707– promoted to Head Strategic Development + Licensing) |
n. a. |
Danaher (Group) |
Germany |
Roscigno, Giorgio (FIND 200601 CEO) |
Chief Executive Officer (CEO) |
FIND – Foundation for Innovative New Diagnostics |
Switzerland |
Rosén, Christer (EffRx 201009 CEO) |
Chief Executive Officer (CEO) |
EffRx Pharmaceuticals S.A. |
Switzerland |
Rosen, Lawrence A. (Qiagen 2013– Supervisory Board Member + Chair since 8/20) |
Supervisory Board Member |
Qiagen (Group) |
Netherlands |
Rosen, Terry (Arcus Biosciences 201609 CEO) |
Chief Executive Officer (CEO) |
Otsuka (Group) |
Japan |
Rosenberg, A. A. (Tony) (TR Advisory Services GmbH 201704 before MPM Capital + Novartis Pharma) |
Chief Executive Officer (CEO) |
TR Advisory Services GmbH |
|
Rosenberg, Adam (Rodin Therapeutics 201601 CEO) |
Chief Executive Officer (CEO) |
Alkermes (Group) |
United States (USA) |
Rosenberg, Marius (Adhesys Medical 2013–201704 Managing Director + Co-Founder) |
n. a. |
Grünenthal (Group) |
Germany |
Rosenberg, Tony (MPM Capital 201711 Managing Director before Novartis + Sandoz) |
Managing Director |
MPM Capital (Group) |
United States (USA) |
Rosenberger, Isabel (AMSilk 202304 Seior Manager Marketing + Communications) |
Sales Manager / Marketing Manager |
AMSilk GmbH |
Germany |
Rosenblum, Gail F. (Bench International 201207 VP Research & Quality joined Bench in 2001) |
Human Resources Manager |
Bench International (Group) |
United States (USA) |
Rosengart, Frau |
n. a. |
BASF (Group) |
Germany |
Rosenkranz, Bernd (Jerini 200306– before HMR + 3ClinicalResearch AG) |
n. a. |
Takeda (Group) |
Germany |
Rosenkranz, Frau (Polytechnos) |
n. a. |
PolyTechnos Funds |
Germany |
Rosenkranz, Hans Jürgen |
n. a. |
Bayer (Group) |
Germany |
Rosenlicht, Jan (Cellca GmbH 201304– Head of Marketing + Sales) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Germany |
Rosenthal, André (Signature Diagnostics 200503) |
n. a. |
Roche (Group) |
Germany |
Rosenthal, Felicia (CellGenix 200501 Managing Director before Metreon Bioproducts 1996– BIO Deutschland 200501) |
Managing Director |
Sartorius (Group) |
Germany |
Rosenthal, Robert J. (Taconic 201406– CEO before Intelligent Medical Implants + Magellan Biosciences + PerkinElmer) |
Chief Executive Officer (CEO) |
Magellan Biosciences (Group) |
United States (USA) |
Rosenthal, Walter (Helmholtz-Gemeinschaft 201202 Chairman of the Board of MDC Berlin) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Roskopf, Oliver (Vitafy Founder + Zalando Founder) |
n. a. |
|
|
Ross, Andy (Fujifilm 202112 Deputy Head of Corp Communications Europe) |
Public Relations Manager / Investor Relations Manager |
Fujifilm (Group) |
Germany |
Ross, Christos (Merck (DE) 201707 EVP Integrated Supply Chain Operations, Life Sciences joined 2008) |
n. a. |
Merck (DE) (Group) |
Germany |
Rossbach, Michael (Eppendorf 201908– Head of Technology Scouting before Vela Diagnostics + Genome Institute of SGP) |
Business Development Manager / Strategy Manager |
Eppendorf (Group) |
Germany |
Rossetti, Luciano (Flagship Pioneering 202101– CMO + Head RnD of Pioneering Medicines before Merck (DE) + Merck (US)) |
Chief Medical Officer (CMO) |
Flagship Pioneering |
United States (USA) |
Rossner, Moritz (LMU 201605 Prof + MPI of Experimental Medicine Göttingen + Co-Founder Systasy Bioscience GmbH) |
Professor |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
Rost, Martin (Zalando Founder) |
n. a. |
|
|
Roters, Florence (Trophic Communications 202002 Business Manager) |
n. a. |
Trophic Communications GmbH |
Germany |
Roth, Christine (Bayer 202203– Head Oncology Strategic Business Unit at Pharma Div before GSK + Novartis + BMS) |
Board member, executive |
Bayer (Group) |
Germany |
Roth, David (Genetrix (ES) 201703– CFO at Sygnis AG before KPMG + Deloitte + Arthur Andersen in the UK) |
Chief Financial Officer (CFO) |
2invest (Group) |
Germany |
Roth, Gerhard (Bruker 200903 Managing Director of Bruker BioSpin) |
Managing Director |
Bruker (Group) |
Germany |
Roth, Günter (BioCopy 202011 CEO + Fonder) |
Chief Executive Officer (CEO) |
BioCopy (Group) |
Germany |
Roth, Lee (Ruth Group 201610) |
Public Relations Manager / Investor Relations Manager |
Ruth Group, The (TRG) |
United States (USA) |
Roth, Matthias (Seiratherm 201202 Managing Director) |
Managing Director |
Seiratherm GmbH |
Germany |
Rothe, Grit (Klocke Group 201706 Managing Director of Oncotec Pharma Produktion GmbH) |
Managing Director |
Klocke (Group) |
Germany |
Rothe, Joachim G. (Life Sciences Partners München 201511 Partner) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
Germany |
Rothel, James (Qiagen 201201 VP Head of Scientific Affairs) |
Research & Development Manager |
Qiagen (Group) |
Germany |
Rothenberg, Mace L. (Pfizer 200810– Senior VP Clinic Development Oncology) |
Research & Development Manager |
Pfizer (Group) |
United States (USA) |
Rothgänger, Jörg (Ridom GmbH 201307 Managing Director) |
Managing Director |
Ridom GmbH |
Germany |
Rothman, Dan (Roivant 201910 Chief Information Officer) |
Chief Information Officer (CIO) / Chief Digital Officer |
Roivant (Group) |
Switzerland |
Rotsch, Friederike (Merck (DE) 201402– Group Legal Counsel joined Merck KGaA 2005) |
General Counsel / Chief Legal Officer (CLO) |
Merck (DE) (Group) |
Germany |
Rotstein, Sergio (Pfizer 201802 Director Medicinal Sciences Business Technology) |
n. a. |
Pfizer (Group) |
United States (USA) |
Rottmann, Lothar (Thermo 201204 Product Manager ICPMS/GDMS before Global Support Manager Inorganic Mass Spectrometry) |
Product Manager (personnel) |
Thermo Fisher (Group) |
Germany |
Rouillé, Arthur (NewCap 202110) |
Public Relations Manager / Investor Relations Manager |
NewCap. – Investor Relations & Financial Communications |
France |
Roussel, Stéphane (ECBF 202202 Partner formerly Managing Director of Solvay Ventures) |
Partner (venture partner) |
ECBF (European Circular Bioeconomy Fund) (Group) |
Germany |
Rouxel, Laetitia (Evotec 202304– CFO before Wavin + Coty + Danone + JnJ + Pfizer) |
Chief Financial Officer (CFO) |
Evotec (Group) |
Germany |
Rowe, Heather (Five Prime 201805 Senior Director IR + Corp Communications) |
Public Relations Manager / Investor Relations Manager |
Five Prime Therapeutics, Inc. (Nasdaq: FPRX) (FivePrime) |
United States (USA) |
Rowland, Charles (Nabriva 201501– Supervisory Board Member before ViroPharma + Endo Pharmaceuticals) |
Supervisory Board Member |
Nabriva (Group) |
Austria |
Roy, Jonathan (Danaher 201612 VP of Pharma Partnerships at Leica Biosystems) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
Germany |
Roy, Subhasis (Novaremed 201808 COO) |
Chief Operating Officer (COO) |
Novaramed AG |
Switzerland |
Royyuru, Ajay (IBM 201007 Senior Manager Computational Biology Dept IBM Research) |
Researcher (industry) |
IBM (Group) |
|
Rozen, Issi (Alphabet 202108 Venture Partner at GV before MIT 201703 CBO at Broad Institute) |
Chief Business Officer (CBO) |
Alphabet (formerly Google) (Group) |
United States (USA) |
Rubin, Dana (Pluristem 202004 Director of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Pluristem (Group) |
Israel |
Rubin, Eric (Merck (US) 201510 VP + Therapeutic Area Head Oncology Early Stage Development MRL) |
President/Director/Head Business Group/Unit/Division |
Merck (US) (MSD) (Group) |
United States (USA) |